These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9296963)

  • 1. [Significance of TSH receptor antibody determination].
    Gannage MH; Haddad F; Jambart S; Atallah C; Halaby G
    J Med Liban; 1996; 44(3):134-7. PubMed ID: 9296963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves' disease (GD): an international multicentre trial.
    Schott M; Hermsen D; Broecker-Preuss M; Casati M; Mas JC; Eckstein A; Gassner D; Golla R; Graeber C; van Helden J; Inomata K; Jarausch J; Kratzsch J; Miyazaki N; Moreno MA; Murakami T; Roth HJ; Stock W; Noh JY; Scherbaum WA; Mann K
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):566-73. PubMed ID: 19170704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TSH receptor antibody (TRAb) assays based on the human monoclonal autoantibody M22 are more sensitive than bovine TSH based assays.
    Zöphel K; Roggenbuck D; von Landenberg P; Wunderlich G; Grüning T; Kotzerke J; Lackner KJ; Rees Smith B
    Horm Metab Res; 2010 Jan; 42(1):65-9. PubMed ID: 19830651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H; Kuwert T; Lohmann T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are porcine and human TSH receptor antibody measurements comparable?
    Zöphel K; von Landenberg P; Roggenbuck D; Wunderlich G; Kotzerke J; Lackner KJ
    Clin Lab; 2008; 54(1-2):1-8. PubMed ID: 18510037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO).
    Giovanella L; Ceriani L; Garancini S
    Q J Nucl Med; 2001 Mar; 45(1):115-9. PubMed ID: 11456370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [TSH anti-receptor antibodies in Graves' disease].
    Sérgio MR; Godinho C; Guerra L; Agapito A; Fonseca F; Costa C
    Acta Med Port; 1996; 9(7-9):229-31. PubMed ID: 9005701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of new different assay systems for thyrotropin receptor antibodies with reference to thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies in Graves' disease.
    Hirooka Y; Li C; Takagi J; Gotoh M; Habu S; Yasaka-Nomura T; Ishihara R; Nakasone Y; Nakamura R; Morikawa R; Otake K; Nogimori T; Ishizuki Y
    Int J Clin Pharmacol Res; 2004; 24(4):111-6. PubMed ID: 15754915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuously increasing sensitivity over three generations of TSH receptor autoantibody assays.
    Zöphel K; Roggenbuck D; Wunderlich G; Schott M
    Horm Metab Res; 2010 Nov; 42(12):900-2. PubMed ID: 20925015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of M22-based ELISA and human-TSH-receptor-based luminescence assay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases.
    Liu C; Hermsen D; Domberg J; Graeber C; Hautzel H; Duan Y; Xu KF; Liu CP; Mao XD; Cupisti K; Scherbaum WA; Schott M
    Horm Metab Res; 2008 Jul; 40(7):479-83. PubMed ID: 18504673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On specificity of 2nd generation TSH receptor autoantibody measurements.
    Zöphel K; Grüning T; Roggenbuck D; Wunderlich G; Kotzerke J
    Clin Lab; 2008; 54(7-8):243-9. PubMed ID: 18942492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding, stimulating and blocking TSH receptor antibodies to the thyrotropin receptor as predictors of relapse of Graves' disease after withdrawal of antithyroid treatment.
    Quadbeck B; Hoermann R; Hahn S; Roggenbuck U; Mann K; Janssen OE
    Horm Metab Res; 2005 Dec; 37(12):745-50. PubMed ID: 16372228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technical evaluation of the first fully automated assay for the detection of TSH receptor autoantibodies.
    Hermsen D; Broecker-Preuss M; Casati M; Mas JC; Eckstein A; Gassner D; van Helden J; Inomata K; Jarausch J; Kratzsch J; Mann K; Miyazaki N; Navarro Moreno MA; Murakami T; Roth HJ; Noh JY; Scherbaum WA; Schott M
    Clin Chim Acta; 2009 Mar; 401(1-2):84-9. PubMed ID: 19091299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytologic differentiation between the autonomous and autoimmune type of diffuse hyperthyroid goiter: correlation with TSH receptor antibodies, microsomal antibodies and infiltrative ophthalmopathy].
    Smoje J; Bistrović D; Ugrai V; Gall D
    Lijec Vjesn; 1989 Dec; 111(12):437-9. PubMed ID: 2636304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in laboratory tests for autoantibodies to thyrotropin receptor protein in Graves' disease.
    Gupta MK
    Clin Lab Med; 1988 Jun; 8(2):303-23. PubMed ID: 3284698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease.
    Bojarska-Szmygin A; Janicki K; Pietura R; Janicka L
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):248-53. PubMed ID: 15314994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current topics on immunological laboratory tests-thyroid diseases].
    Iwatani Y
    Rinsho Byori; 2004 Sep; 52(9):751-8. PubMed ID: 15552935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thyrotropin receptor antibodies (TRAb) as a test of surgical treatment effectiveness in Graves-Basedow's diseases].
    Bojarska-Szmygin A; Ciechanek R; Jezierska B; Zaorska-Rajca J
    Pol Merkur Lekarski; 2002 Sep; 13(75):196-9. PubMed ID: 12474569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved prediction of relapse of Graves' thyrotoxicosis by combined determination of TSH receptor and thyroperoxidase antibodies.
    Schott M; Eckstein A; Willenberg HS; Nguyen TB; Morgenthaler NG; Scherbaum WA
    Horm Metab Res; 2007 Jan; 39(1):56-61. PubMed ID: 17226115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of combining tests of thyroid autoantibodies in differential diagnosis between Graves's disease and Hashimoto's hyperthyroidism].
    Hu YM; Liu W; Lu GH
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):940-2. PubMed ID: 12899792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.